CardioGenics Holdings Inc (CGNH)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2015 | 772.14 Thousand USD | -20.68% |
| 2014 | 973.5 Thousand USD | -58.18% |
| 2013 | 2.32 Million USD | 80.44% |
| 2012 | 1.29 Million USD | -65.53% |
| 2011 | 3.74 Million USD | 99.42% |
| 2010 | 1.87 Million USD | -41.35% |
| 2009 | 3.19 Million USD | 66.63% |
| 2008 | 1.92 Million USD | 3.74% |
| 2007 | 1.85 Million USD | -23.77% |
| 2006 | 2.42 Million USD | 35.75% |
| 2005 | 1.78 Million USD | -8.99% |
| 2004 | 1.96 Million USD | -11.81% |
| 2003 | 2.22 Million USD | -36.24% |
| 2002 | 3.49 Million USD | -59.56% |
| 2001 | 8.64 Million USD | 10.46% |
| 2000 | 7.82 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2016 Q1 | 201.09 Thousand USD | -35.49% |
| 2015 Q4 | 311.73 Thousand USD | 212.03% |
| 2015 FY | 772.14 Thousand USD | -20.68% |
| 2015 Q1 | 205.69 Thousand USD | -33.32% |
| 2015 Q2 | 154.8 Thousand USD | -24.74% |
| 2015 Q3 | 99.9 Thousand USD | -35.47% |
| 2014 FY | 973.5 Thousand USD | -58.18% |
| 2014 Q3 | 197.45 Thousand USD | -3.86% |
| 2014 Q4 | 308.48 Thousand USD | 56.23% |
| 2014 Q1 | 262.17 Thousand USD | -84.39% |
| 2014 Q2 | 205.39 Thousand USD | -21.66% |
| 2013 Q4 | 1.67 Million USD | 618.95% |
| 2013 FY | 2.32 Million USD | 80.44% |
| 2013 Q3 | 233.62 Thousand USD | 20.99% |
| 2013 Q2 | 193.09 Thousand USD | -12.8% |
| 2013 Q1 | 221.43 Thousand USD | -33.68% |
| 2012 Q1 | 336.06 Thousand USD | -29.47% |
| 2012 Q4 | 333.88 Thousand USD | 42.48% |
| 2012 FY | 1.29 Million USD | -65.53% |
| 2012 Q3 | 234.34 Thousand USD | -39.26% |
| 2012 Q2 | 385.81 Thousand USD | 14.81% |
| 2011 FY | 3.74 Million USD | 99.42% |
| 2011 Q1 | 461.43 Thousand USD | 6.8% |
| 2011 Q2 | 624.44 Thousand USD | 35.33% |
| 2011 Q4 | 476.51 Thousand USD | -78.14% |
| 2011 Q3 | 2.17 Million USD | 249.08% |
| 2010 Q3 | 665.78 Thousand USD | 92.25% |
| 2010 FY | 1.87 Million USD | -41.35% |
| 2010 Q2 | 346.31 Thousand USD | -19.9% |
| 2010 Q1 | 432.35 Thousand USD | 11.75% |
| 2010 Q4 | 432.04 Thousand USD | -35.11% |
| 2009 Q1 | 454.86 Thousand USD | 73.28% |
| 2009 FY | 3.19 Million USD | 66.63% |
| 2009 Q4 | 386.89 Thousand USD | -85.53% |
| 2009 Q2 | 149.09 Thousand USD | -67.22% |
| 2009 Q3 | 2.67 Million USD | 1693.18% |
| 2008 Q3 | 306.49 Thousand USD | -48.87% |
| 2008 Q1 | 569.81 Thousand USD | 28.19% |
| 2008 FY | 1.92 Million USD | 3.74% |
| 2008 Q4 | 262.5 Thousand USD | -14.35% |
| 2008 Q2 | 599.42 Thousand USD | 5.2% |
| 2007 FY | 1.85 Million USD | -23.77% |
| 2007 Q4 | 444.52 Thousand USD | -40.52% |
| 2007 Q3 | 747.29 Thousand USD | 53.61% |
| 2007 Q2 | 486.49 Thousand USD | 37.67% |
| 2007 Q1 | 353.37 Thousand USD | 33.88% |
| 2006 Q4 | 263.95 Thousand USD | -41.37% |
| 2006 Q3 | 450.23 Thousand USD | -40.06% |
| 2006 Q2 | 751.17 Thousand USD | 8.71% |
| 2006 Q1 | 690.98 Thousand USD | 28.91% |
| 2006 FY | 2.42 Million USD | 35.75% |
| 2005 Q1 | 616.26 Thousand USD | 144.96% |
| 2005 FY | 1.78 Million USD | -8.99% |
| 2005 Q4 | 536.03 Thousand USD | 40.75% |
| 2005 Q3 | 380.83 Thousand USD | -29.5% |
| 2005 Q2 | 540.22 Thousand USD | -12.34% |
| 2004 Q2 | 709.02 Thousand USD | 149.47% |
| 2004 FY | 1.96 Million USD | -11.81% |
| 2004 Q4 | 251.57 Thousand USD | -50.16% |
| 2004 Q1 | 284.21 Thousand USD | -39.21% |
| 2004 Q3 | 504.8 Thousand USD | -28.8% |
| 2003 Q1 | 544.7 Thousand USD | 17.24% |
| 2003 Q4 | 467.53 Thousand USD | 18.32% |
| 2003 FY | 2.22 Million USD | -36.24% |
| 2003 Q3 | 395.13 Thousand USD | -52.07% |
| 2003 Q2 | 824.33 Thousand USD | 51.34% |
| 2002 Q3 | 624.09 Thousand USD | -31.39% |
| 2002 Q2 | 909.58 Thousand USD | -24.87% |
| 2002 Q1 | 1.21 Million USD | 61.16% |
| 2002 FY | 3.49 Million USD | -59.56% |
| 2002 Q4 | 464.59 Thousand USD | -25.56% |
| 2001 FY | 8.64 Million USD | 10.46% |
| 2001 Q3 | 769.04 Thousand USD | -42.36% |
| 2001 Q2 | 1.33 Million USD | -47.9% |
| 2001 Q1 | 2.56 Million USD | -36.02% |
| 2001 Q4 | 751.22 Thousand USD | -2.32% |
| 2000 Q1 | 1.71 Million USD | 0.0% |
| 2000 FY | 7.82 Million USD | 0.0% |
| 2000 Q4 | 4 Million USD | 106.22% |
| 2000 Q2 | 3.06 Million USD | 78.34% |
| 2000 Q3 | 1.94 Million USD | -36.65% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Bio Medica Corporation | 1.04 Million USD | 26.393% |
| Arrayit Corporation | 6.19 Million USD | 87.541% |
| Atlantic International Corp. | 5.57 Million USD | 86.158% |
| Biocept, Inc. | 29.4 Million USD | 97.374% |
| Bioqual, Inc. | 7.44 Million USD | 89.634% |
| DermTech, Inc. | 104.01 Million USD | 99.258% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 166.5 Million USD | 99.536% |
| HTG Molecular Diagnostics, Inc. | 22.62 Million USD | 96.587% |
| iMD Companies, Inc. | 151.8 Thousand USD | -408.627% |
| IDenta Corp. | 662.97 Thousand USD | -16.466% |
| Interpace Biosciences, Inc. | 20.23 Million USD | 96.184% |
| Integrative Health Technologies, Inc. | 38.88 Thousand USD | -1885.911% |
| InVitro International | 661.32 Thousand USD | -16.757% |
| Lumos Diagnostics Holdings Limited | 7.09 Million USD | 89.122% |
| Many Bright Ideas Technologies Inc. | 58.11 Thousand USD | -1228.714% |
| Medical Imaging Corp. | 1.91 Million USD | 59.619% |
| NovelStem International Corp. | 3.53 Million USD | 78.175% |
| Optigenex Inc. | 1.28 Million USD | 40.045% |
| PharmChem, Inc. | 2.93 Million USD | 73.658% |
| Proteome Sciences plc | 3.26 Million USD | 76.373% |
| Response Genetics, Inc | 25.31 Million USD | 96.95% |
| Rennova Health, Inc. | 7.67 Million USD | 89.943% |
| RushNet, Inc. | 1.78 Million USD | 56.847% |
| ScreenPro Security Inc. | 3.23 Million USD | 76.16% |
| Stella Diagnostics Inc. | 11.42 Million USD | 93.243% |
| StageZero Life Sciences Ltd. | 7.34 Million USD | 89.485% |
| Todos Medical Ltd. | 14.05 Million USD | 94.507% |